热门资讯> 正文
AnaptysBio任命Christopher Murphy为首席财务官
2026-05-11 21:25
- AnaptysBio (ANAB) on Monday announced the appointment of Christopher Murphy as Chief Financial Officer.
- Murphy, previously, served as CFO and CBO of Third Harmonic Bio. Before Third Harmonic, he served as a senior leader at Horizon Therapeutics.
- The company also appointed Owen Hughes as a member of its Board of Directors.
More on AnaptysBio
- AnaptysBio: 'Hold' As Spin-Off Shifts Pipeline To First Tracks Biotherapeutics
- AnaptysBio: Upside Constrained By Undifferentiated Data, Legal Uncertainties
- GSK subsidiary Tesaro, AnaptysBio provide update on contract claim litigation
- AnaptysBio rises after completing First Tracks spinoff
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。